作者：
Marika,Watanabe [1]
;
Kimikazu,Yakushijin [1]
;
Yohei,Funakoshi [1]
;
Goh,Ohji [2]
;
Wataru,Hojo [3]
;
Hironori,Sakai [3]
;
Miki,Saeki [1]
;
Yuri,Hirakawa [1]
;
Sakuya,Matsumoto [1]
;
Rina,Sakai [1]
;
Shigeki,Nagao [1]
;
Akihito,Kitao [1]
;
Yoshiharu,Miyata [4]
;
Taiji,Koyama [1]
;
Yasuyuki,Saito [5]
;
Shinichiro,Kawamoto [1]
;
Mitsuhiro,Ito [1]
;
Tohru,Murayama [6]
;
Hiroshi,Matsuoka [1]
;
Hironobu,Minami [7]
作者单位：
Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
[1]
Division of Infectious Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
[2]
R&D, Cellspect Co., Ltd., Morioka 020-0857, Japan.
[3]
BioResource Center, Kobe University Hospital, Kobe 650-0047, Japan.
[4]
Division of Molecular and Cellular Signaling, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
[5]
Laboratory of Hematology, Division of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe 654-0142, Japan.
[6]
Hematology Division, Hyogo Cancer Center, Akashi 673-0021, Japan.
[7]
Cancer Center, Kobe University Hospital, Kobe 650-0017, Japan.
[8]
DOI
10.3390/vaccines10020158
PMID
35214617
发布时间
2022-03-01
换一批
换一批
